Join
Live feed
·
PRReleasevia Quantisnow
MorphoSys AG logo

MorphoSys' Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study

ByQuantisnow·Wall Street's wire, on your screen.
MOR· MorphoSys AG
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MOR (MorphoSys AG) and more on Quantisnow.